Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study

BACKGROUND/AIMS: This study assessed the efficacy and safety of adalimumab (ADA) and explored predictors of response in Korean patients with ulcerative colitis (UC). METHODS: A prospective, observational, multicenter study was conducted over 56 weeks in adult patients with moderately to severely act...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seung Yong, Park, Soo Jung, Kim, Young, Im, Jong Pil, Kim, Hyo Jong, Lee, Kang-Moon, Kim, Ji Won, Jung, Sung-Ae, Lee, Jun, Kang, Sang-Bum, Shin, Sung Jae, Kim, Eun Sun, Kim, You Sun, Kim, Tae Oh, Kim, Hyun-Soo, Park, Dong Il, Kim, Hyung Kil, Kim, Eun Soo, Kim, Young-Ho, Kim, Do Hyun, Teng, Dennis, Kim, Jong-Hwa, Kim, Wonyong, Choi, Chang Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344242/
https://www.ncbi.nlm.nih.gov/pubmed/34289648
http://dx.doi.org/10.5217/ir.2021.00049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344242/
https://www.ncbi.nlm.nih.gov/pubmed/34289648
http://dx.doi.org/10.5217/ir.2021.00049

Ejemplares similares